PTEN and cancer: Thus PTEN is an enticing therapeutic target for activation since it is frequently inactivated in many human cancers through point mutations as well as other genetic and biochemical mechanisms [e.g., promoter hypermethylation, gene deletion, expression of various interacting proteins, miRNAs, phosphorylation, acetylation, ubiquitination, oxidization and others].